Culprit, Complete, or Cautious? 🔧❤️🕰️": Decoding Revascularisation Timing in STEMI

🚨 New insights from the Lancet! 🚑 In the OPTION–STEMI trial, immediate multivessel PCI during the index procedure failed to show non-inferiority compared to staged revascularisation in STEMI patients with multivessel disease.   🧠 Key takeaway? Timing matters. ⚠️ Higher risk in those with heart failure (Killip II/III) 💡 Safer strategy: staged PCI for high-risk patients   📊 Fractional flow reserve, procedural MI, and guideline implications all in focus. A must-read for interventionalists & clinical guideline leaders.   🔗 https://doi.org/10.1016/S0140-6736(25)01529-6 #STEMI #PCI #InterventionalCardiology #Lancet #CardioTwitter #Revascularisation #KillipClass #FFR #ClinicalTrials #Cardiology ❤️🫀